-
Shanghai sampling 6 categories of food 544 batches of samples 1 batch of icing sugar test excellent value is not qualified
Time of Update: 2020-12-07
batch of sugar, for: the label Shanghai Yilong Industrial Co. , Ltd. branch production of yellow icing sugar (specification model: 400 g / bag production date / lot number: 2020-04-01) inspection excellent value is not qualified, the detection value
-
Chongqing announced the outbreak prevention and control period of food special sampling situation 1 batch of food testing out of non-conformity
Time of Update: 2020-11-30
Food Partners Network News March 16, Chongqing Municipal Market Supervision and Administration announced the outbreak prevention and control of food special sampling situation.
-
Roche announced that the FDA has approved its first HIV-1/HIV-2 qualitative test reagent.
Time of Update: 2020-10-15
personalized care while curbing further spread of the disease. cobas HIV-1/HIV-2 qualitative testing reagent is an in-body nucleic acid amplification reagent used to assist in the diagnosis of HIV-1/HIV-2 infection. HIV-1 or HIV-2 nucleic acids
-
Roche's first HIV-1/HIV-2 qualitative test reagent was approved by the FDA.
Time of Update: 2020-09-20
the cobas HIV-1/HIV-2 qualitative test, when used with PCR technology, will be more sensitive and can quickly identify infections, allowing treatment based on the type of HIV infection.
-
Sci Adv: Vaccine for type 1 diabetes-related viruses successfully tested in animal models
Time of Update: 2020-06-25
The vaccine was tested in different animal models and the results showed that it protected infected CVB mice from viral-induced type 1 diabetes.
-
[news] 2020/1/21 novel coronavirus pneumonia cases were diagnosed by 15 medical staff in Wuhan.
Time of Update: 2020-01-21
Novel coronavirus novel coronavirus pneumonia was diagnosed in 15 medical staff in Wuhan
The Wuhan municipal health and Health Committee announced the official health
-
From March 1, 21 drugs with rare diseases will be reduced by 3%
Time of Update: 2019-02-25
[China Pharmaceutical network industry trends] on February 22, four ministries and commissions including the drug regulatory bureau announced the notice on the value-added tax policy of rare disease drugs.
-
The first domestic PD-1 has been approved for listing! Facing the price test!
Time of Update: 2018-12-26
As the first domestic monoclonal antibody with PD-1 as the target drug approved for marketing in China, trepril mAb has been supported by major national science and technology projects.
-
Global phase 2 test of PD-1 antibody initiated by Baiji Shenzhou
Time of Update: 2018-04-11
The company today announced that it is developing a global phase 2 clinical trial of anti-PD-1 antibody tislilizumab for patients with previously treated advanced liver cancer (HCC or liver cancer) to achieve the first patient administration.
-
The top 10-year sales of chemical injection exceed 3 billion yuan. Who can break through 21 class 1 "new drugs"?
Time of Update: 2018-04-02
Recently, the drug evaluation center (CDE) of the State Food and Drug Administration issued the technical guidance on drug injection research and development, which is applicable
-
Inventory: 21 "China class 1" anti-tumor drugs under research in clinical phase III (Part 2)
Time of Update: 2018-03-22
Source: Yaodu Toutiao 2018-03-22 in the previous "inventory: 21 ongoing" class 1 "anti-tumor drugs in research (Part I)" in clinical phase III, the author summarized 21 "clinical
-
Inventory: 21 "China class 1" anti-tumor drugs under research in clinical phase III (Part I)
Time of Update: 2018-03-21
Source: Yaodu data March 21, 2018 Phase III clinical research is like a football match
The success or failure is always at one stroke
Anti-tumor drugs
-
21 "China class 1" antitumor drugs under research in clinical phase III (Part I)
Time of Update: 2018-03-21
Phase III clinical research is like a football match
The success or failure is always at one stroke
Anti-tumor drugs are the hottest direction of drug
